190 related articles for article (PubMed ID: 35514958)
41. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
42. Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus.
Alahlafi A; Wordsworth P; Wojnarowska F
J Cutan Pathol; 2005 Sep; 32(8):537-40. PubMed ID: 16115051
[TBL] [Abstract][Full Text] [Related]
43. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
44. The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution.
Yu H; Hong X; Wu H; Zheng F; Zeng Z; Dai W; Yin L; Liu D; Tang D; Dai Y
Front Immunol; 2021; 12():641886. PubMed ID: 34084162
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
46. MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
Ugarte-Berzal E; Boon L; Martens E; Rybakin V; Blockmans D; Vandooren J; Proost P; Opdenakker G
Front Immunol; 2019; 10():538. PubMed ID: 30967870
[TBL] [Abstract][Full Text] [Related]
47. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
Saegusa J; Kawano S; Morinobu A
Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
[TBL] [Abstract][Full Text] [Related]
48. Microbiome and Metabolome Analyses Reveal the Disruption of Lipid Metabolism in Systemic Lupus Erythematosus.
He J; Chan T; Hong X; Zheng F; Zhu C; Yin L; Dai W; Tang D; Liu D; Dai Y
Front Immunol; 2020; 11():1703. PubMed ID: 32849599
[TBL] [Abstract][Full Text] [Related]
49. Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.
Ferreira TAR; de Andrade HM; de Pádua PM; Carvalho MDG; Pires SDF; Oliveira IHR; Lima BSS; Fialho Júnior LC; Cicarini WB; Chapeourouge DA; Perales JH; Guimarães TMPD; Toledo VPCP
Autoimmunity; 2017 Jun; 50(4):247-256. PubMed ID: 28675715
[TBL] [Abstract][Full Text] [Related]
50. Serum proteomics study reveals candidate biomarkers for systemic lupus erythematosus.
Zhong L; Liu J; Zhou J; Sun L; Li C; Li X; Liu R; Zhao J; Yang B; Liu X; Deng X
Int J Clin Exp Pathol; 2017; 10(10):10681-10694. PubMed ID: 31966412
[TBL] [Abstract][Full Text] [Related]
51. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention.
Zhang L; Qing P; Yang H; Wu Y; Liu Y; Luo Y
Front Immunol; 2021; 12():686501. PubMed ID: 34335588
[TBL] [Abstract][Full Text] [Related]
52. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
53. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
54. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
55. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
Wu Q; Yang Q; Sun H
Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
[TBL] [Abstract][Full Text] [Related]
56. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.
Jung JY; Suh CH
Korean J Intern Med; 2017 May; 32(3):429-438. PubMed ID: 28490724
[TBL] [Abstract][Full Text] [Related]
57. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
58. Transcellular distribution heterogeneity of Annexin A5 represents a protective response to lupus-related thrombophilia: a pilot Proteomics-based study.
Zhou D; Luo N; Wu Q; You Y; Zhai Z; Mou Z; Wu Y; Hao F
Biochem Biophys Res Commun; 2012 Apr; 420(2):357-63. PubMed ID: 22425772
[TBL] [Abstract][Full Text] [Related]
59. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
[TBL] [Abstract][Full Text] [Related]
60. Activation status of CD56
Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
